Registries: Supercharging Real-World Evidence for Drug Development and Approval

Unlock the power of real-world evidence (RWE) in drug development with protocol-based disease registries. These clinically rich sources of real-world data (RWD) are purpose-built for research, offering valuable insights into treatment patterns, effectiveness outcomes and the natural history of diseases.

In this webinar, a panel of industry leaders explore:

• The types of RWD that can be collected in registries
• How RWD can be used to conduct nested, customized registry-based studies
• How to ensure data are collected consistently across patients, practice settings, geography and time
• How to determine if and what kind of registry you require
• What regulators say about using RWD from registries to inform their decision making
• Whether registry data can be used and linked to other data sources
• How to get from data to actionable insights